Pulse Biosciences (PLSE) Return on Sales (2021 - 2026)

Pulse Biosciences (PLSE) posted quarterly Return on Sales of 3.48% for Q3 2025, down 80.91% quarter-over-quarter from 1.93% in Q1 2023.

Pulse Biosciences (PLSE) Return on Sales (2021 - 2026) Analysis & Trends

Pulse Biosciences' Return on Sales history runs 4 years deep, the most recent figure standing at 3.48% for Q3 2025.

In Q3 2025, Return on Sales changed N/A year-over-year to 3.48%; the TTM figure through Sep 2025 stood at 2.54% (changed N/A YoY), while the FY2022 annual figure was 0.84%, down 38.0% from the prior year.
Return on Sales for Q3 2025 stood at 3.48%, down from 1.93% in the prior quarter.
The five-year high for Return on Sales was 0.19% in Q4 2021, with the low at 3.48% in Q3 2025.
The 4-year median for Return on Sales is 0.48% (2022), against an average of 1.0%.
The sharpest annual moves came in 2022 and 2023: Return on Sales decreased 16 bps in 2022, then sank 154 bps in 2023.
Pulse Biosciences' Return on Sales stood at 0.19% in 2021, then plunged by 341 bps to 0.83% in 2022, then sank by 133 bps to 1.93% in 2023, then plunged by 81 bps to 3.48% in 2025.
Business Quant data shows PLSE's Return on Sales at 3.48% in Q3 2025, 1.93% in Q1 2023, and 0.83% in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Intuitive Surgical	134.22 Bn	129.00 Bn	1.96 Bn	0.00%
2	Becton Dickinson	52.42 Bn	51.56 Bn	2.32 Bn	0.00%
3	Alcon	35.74 Bn	34.39 Bn	1.68 Bn	0.00%
4	Resmed	33.89 Bn	32.42 Bn	861.22 Mn	0.00%
5	Medline	28.89 Bn	26.21 Bn	2.22 Bn	0.00%
6	West Pharmaceutical Services	25.07 Bn	24.64 Bn	329.20 Mn	0.00%
7	Solventum	15.30 Bn	14.90 Bn	1.29 Bn	0.00%
8	Cooper Companies	14.83 Bn	14.69 Bn	735.40 Mn	0.00%
9	Baxter International	13.62 Bn	11.47 Bn	1.03 Bn	0.00%
10	Pulse Biosciences	3.40 Bn	3.40 Bn	161,000.00	-0.57%

Download Data